Announcement
·
06 May 2025
·
M42 appoints Dimitris Moulavasilis as Group CEO

One of the UAE’s flagship health initiatives, combining advanced genomic research with the power of precision medicine.

By mapping the genetic makeup of Emiratis, the program is helping healthcare providers anticipate risks for hereditary conditions, inform public health policies, and create personalized, preventive and predictive health strategies

Visit Website
  • Icon Recognition

    780K UAE Nationals took part in the EGP.

  • Icon Government Building

    1,123+ government and private organizations supported and collaborated with the program

Other Assets

    Biogenix Labs

    Unlocking the future of precision health.

    IROS

    A UAE-based Clinical or Contract Research Organization (CRO), advancing patient care and health innovation through high quality research and groundbreak...

    Environmental Sciences

    A health-tech division of M42 that focuses on interdisciplinary research and analysis of non-human factors affecting the environment and public health. ...

    Gensense

    Empowering your health and wellness with Gensense’s wellbeing and gut health tests.

    Abu Dhabi Biobank

    A leading regional hub for biobanking excellence, leveraging extensive biological and medical data to drive scientific breakthroughs. It accelerates dru...